Literature DB >> 19706851

FDA panel OKs 3 antipsychotic drugs for pediatric use, cautions against overuse.

Bridget M Kuehn.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19706851     DOI: 10.1001/jama.2009.1152

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Antipsychotics for children: can we do better?

Authors:  Normand Carrey
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2010-05

2.  Early-life risperidone enhances locomotor responses to amphetamine during adulthood.

Authors:  Bobbie Lee Stubbeman; Clifford J Brown; Justin R Yates; Mark E Bardgett
Journal:  Eur J Pharmacol       Date:  2017-07-14       Impact factor: 4.432

3.  Relationships between the use of second-generation antipsychotics and changes in total cholesterol levels in children and adolescents perinatally infected with HIV.

Authors:  Suad Kapetanovic; Lisa Aaron; Paige L Williams; John Farley; Patricia A Sirois; Patricia A Garvie; Deborah A Pearson; James M Oleske; Grace Montepiedra
Journal:  Neurobehav HIV Med       Date:  2010-08

Review 4.  Safety and pharmacokinetics of atypical antipsychotics in children and adolescents.

Authors:  Silvio Caccia
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

5.  Adult rats treated with risperidone during development are hyperactive.

Authors:  Mark E Bardgett; Julie M Franks-Henry; Kristin R Colemire; Kathleen R Juneau; Rachel M Stevens; Cecile A Marczinski; Molly S Griffith
Journal:  Exp Clin Psychopharmacol       Date:  2013-06       Impact factor: 3.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.